Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Semmling, V., Lukacs-Kornek, V., Thaiss, C.A., Quast, T., Hochheiser, K., Panzer, U.,
Rossjohn, J., Perlmutter, P., Cao, J., Godfrey, D.I., et al. (2010). Alternative cross-priming
through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat
Immunol 11, 313-320.
Shiow, L.R., Rosen, D.B., Brdickova, N., Xu, Y., An, J., Lanier, L.L., Cyster, J.G., and
Matloubian, M. (2006). CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and
lymphocyte egress from lymphoid organs. Nature 440, 540-544.
Shirai, M., Pendleton, C.D., Ahlers, J., Takeshita, T., Newman, M., and Berzofsky, J.A.
(1994). Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of
anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J Immunol 152, 549-556.
Shirota, H., and Klinman, D.M. (2011). CpG-conjugated apoptotic tumor cells elicit potent
tumor-specific immunity. Cancer Immunol Immunother 60, 659-669.
Sondak, V.K., and Sosman, J.A. (2003). Results of clinical trials with an allogenic melanoma
tumor cell lysate vaccine: Melacine. Semin Cancer Biol 13, 409-415.
Spadaro, F., Lapenta, C., Donati, S., Abalsamo, L., Barnaba, V., Belardelli, F., Santini, S.M.,
and Ferrantini, M. (2012). IFN-alpha enhances cross-presentation in human dendritic cells by
modulating antigen survival, endocytic routing, and processing. Blood 119, 1407-1417.
Sporri, R., and Reis e Sousa, C. (2005). Inflammatory mediators are insufficient for full
dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper
function. Nat Immunol 6, 163-170.
Steinman, R.M. (2003). Some interfaces of dendritic cell biology. APMIS 111, 675-697.
Steinman, R.M., and Nussenzweig, M.C. (2002). Avoiding horror autotoxicus: the importance
of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99, 351-358.
Stemberger, C., Huster, K.M., Koffler, M., Anderl, F., Schiemann, M., Wagner, H., and
Busch, D.H. (2007). A single naive CD8+ T cell precursor can develop into diverse effector
and memory subsets. Immunity 27, 985-997.
Storni, T., Ruedl, C., Renner, W.A., and Bachmann, M.F. (2003). Innate immunity together
with duration of antigen persistence regulate effector T cell induction. J Immunol 171, 795-
801.
Strasser, A. (2005). The role of BH3-only proteins in the immune system. Nat Rev Immunol
5, 189-200.
Sung, S.S., Fu, S.M., Rose, C.E., Jr., Gaskin, F., Ju, S.T., and Beaty, S.R. (2006). A major
lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing
Langerin and tight junction proteins. J Immunol 176, 2161-2172.
Takemoto, N., Intlekofer, A.M., Northrup, J.T., Wherry, E.J., and Reiner, S.L. (2006). Cutting
Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced
CD8+ T cell differentiation. J Immunol 177, 7515-7519.
Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell 140,
805-820.
Thompson, L.J., Kolumam, G.A., Thomas, S., and Murali-Krishna, K. (2006). Innate
inflammatory signals induced by various pathogens differentially dictate the IFN-I
dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 177,
1746-1754.
Page 251 of 256